Fundz

Ambrx Appoints Renu Vaish, M.Sc., as Chief Regulatory Officer to Lead Regulatory Affairs

PRIVATEAug 01, 2023

Position

Chief Regulatory Officer

Company

Ambrx

Renu Vaish
renu.vaish@ambrx.com
San DiegoBiotechnologyHealth CareTherapeuticsBiopharma

Description

SAN DIEGO , Aug. 01, 2023 -- Ambrx Biopharma Inc. , today announced the appointment of Renu Vaish , M.Sc ., as Chief Regulatory Officer

Quick answer

Ambrx Appoints Renu Vaish, M.Sc., as Chief Regulatory Officer to Lead Regulatory Affairs (August 1, 2023). Ambrx is based in San Diego, California, United States.

Who is the new Chief Regulatory Officer at Ambrx?
Ambrx named Renu Vaish Chief Regulatory Officer, announced August 1, 2023.
What did Ambrx announce on August 1, 2023?
SAN DIEGO , Aug. 01, 2023 -- Ambrx Biopharma Inc. , today announced the appointment of Renu Vaish , M.Sc ., as Chief Regulatory Officer
What does Ambrx do?
Ambrx Biopharma, Inc. is a clinical-stage biopharmaceutical company that specializes in developing next-generation antibody drug conjugates (ADCs) using a proprietary synthetic biology technology platform.
Where is Ambrx based?
Ambrx is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Karuna Therapeutics (August 3, 2023), Pfizer (July 27, 2023), LumaBridge (August 8, 2023) and Acadia Pharmaceuticals (July 25, 2023) also announced leadership changes within 45 days of Ambrx.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Ambrx, and when

A new leader at Ambrx brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Ambrx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ambrx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ambrx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ambrx

Location

San Diego, California, United States

About

Ambrx Biopharma, Inc. is a clinical-stage biopharmaceutical company that specializes in developing next-generation antibody drug conjugates (ADCs) using a proprietary synthetic biology technology platform. The company is focused on advancing targeted oncology therapeutics and improving the treatment options for patients with cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ambrx changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Renu
Likely contact at this company
••••••••@••••••••

See Renu's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Ambrx's next move

Learn about Strategic plan

Ambrx changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.